EconPapers    
Economics at your fingertips  
 

PharmacoEconomics

1997 - 2025

Current editor(s): Timothy Wrightson and Christopher I. Carswell

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.


Volume 43, issue 6, 2025

Using AI in the Economic Evaluation of AI-Based Health Technologies pp. 597-600 Downloads
Salah Ghabri
A Review of Heterogeneity in Comparative Economic Analysis, with Specific Considerations for the Decentralized US Setting and Patient-Centered Care pp. 601-616 Downloads
Michael S. Willis, Andreas Nilsson and Cheryl A. Neslusan
What are the Revealed and Stated Population Preferences for Environmental Sustainability in Healthcare? A Scoping Review pp. 617-627 Downloads
Charlotte Desterbecq, Mark Harrison and Sandy Tubeuf
Correction: What are the Revealed and Stated Population Preferences for Environmental Sustainability in Healthcare? A Scoping Review pp. 629-629 Downloads
Charlotte Desterbecq, Mark Harrison and Sandy Tubeuf
Economic Evaluation of Interventions to Reduce Antimicrobial Resistance: A Systematic Literature Review of Methods pp. 631-646 Downloads
Kristina Aluzaite, Marta O. Soares, Catherine Hewitt, Julie Robotham, Chris Painter and Beth Woods
Artificial Intelligence as a New Research Ally? Performing AI-Assisted Systematic Literature Reviews in Health Economics pp. 647-650 Downloads
Sietse Mossel, Martijn Johan Oude-Wolcherink, Rafael Emilio Feria Cardet, Lioe-Fee Geus-Oei, Dennis Vriens, Hendrik Koffijberg and Sopany Saing
Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA pp. 651-664 Downloads
Hiral Anil Shah, Ginita Jutlla, Oscar Herrera-Restrepo, Jonathan Graham, Mei Grace, Shah Alam Khan, Elise Kuylen, Shahina Begum, Frederik Verelst and Zeki Kocaata
Making Composite Time Trade-Off Sensitive for Worse-than-Dead Health States pp. 665-675 Downloads
Michał Jakubczyk, Bram Roudijk, Stefan A. Lipman and Peep Stalmeier
The Monetary Value of a Statistical Life in the Context of Atherosclerotic Cardiovascular Disease pp. 677-689 Downloads
Jorge-Eduardo Martínez-Pérez, Fernando-Ignacio Sánchez-Martínez, José-María Abellán-Perpiñán and Domingo Pascual-Figal

Volume 43, issue 5, 2025

Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective pp. 469-472 Downloads
Cyril Onwuelazu Uteh, Eugenie Evelynne Johnson, Tomos Robinson, Najmeh Moradi, Alex Inskip, Fiona R. Beyer, Katie Thomson and Gurdeep S. Sagoo
A Taxonomy for Assessing Whether HRQoL Value Sets Are Obsolete pp. 473-481 Downloads
Richard Norman, Bram Roudijk, Marcel Jonker, Elly Stolk, Saskia Knies, Raoh-Fang Pwu, Ciaran O’Neill, Kirsten Howard and Nancy Devlin
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology pp. 483-497 Downloads
Astrid Kramer, Lucas F. Schaik, Daan Broek, Gerrit A. Meijer, Iñaki Gutierrez Ibarluzea, Lorea Galnares Cordero, Remond J. A. Fijneman, Marjolijn J. L. Ligtenberg, Ed Schuuring, Wim H. Harten, Veerle M. H. Coupé and Valesca P. Retèl
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal Haemoglobinuria pp. 499-508 Downloads
Jeremiah Donoghue, Matthew Youngs, Alex Reeve, Krishna Vydyula, Natalia Kunst, Roochi Trikha and Daniel Gallacher
Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice pp. 509-520 Downloads
Adam Fridhammar, Oskar Frisell, Karin Wahlberg, Emelie Berglund, Pontus Röbeck and Sofie Persson
Acceptance of Evidence Transfer Within German Early Benefit Assessment of New Drugs for Pediatric and Adolescents Target Populations pp. 521-553 Downloads
Georgia Pick, Dirk Müller and Charalabos-Markos Dintsios
EQ-5D-5L or EQ-HWB-S: Which is the Better Instrument for Capturing Spillover Effects in Parental Carers of Children with COVID-19? pp. 555-567 Downloads
Wenjing Zhou, Bo Ding, Jan Busschbach, Michael Herdman, Zhihao Yang and Yanming Lu
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection pp. 569-582 Downloads
Florian Zeevat, Simon Pol, Alexia Kieffer, Maarten J. Postma and Cornelis Boersma
Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI’s Gene Therapy Access Model pp. 583-594 Downloads
Antal Zemplenyi, Jim Leonard, Garth C. Wright, Michael J. DiStefano, Kavita Nair, Kelly E. Anderson and R. Brett McQueen
Correction: De Novo Cost‑Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation pp. 595-596 Downloads
Peter Gal, Gyorgyi Feldmajer, Margarida Augusto, Ray Gani, Emma Hook, Ash Bullement, Zoe Philips and Inger Smith

Volume 43, issue 4, 2025

A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence pp. 363-373 Downloads
Beth Woods, Alfredo Palacios and Mark Sculpher
Projections of Public Spending on Pharmaceuticals: A Review of Methods pp. 375-388 Downloads
Irina Odnoletkova, Patrice X. Chalon, Stephan Devriese and Irina Cleemput
How Does Bereavement Affect the Health-Related Quality of Life of Household Members Who Do and Do Not Provide Unpaid Care? Difference-in-Differences Analyses Using the UK Household Longitudinal Survey pp. 389-402 Downloads
Becky Pennington, Mónica Hernández Alava and Mark Strong
Value of Innovative Multiple Myeloma Treatments from Patient and Healthcare Provider Perspectives: Evidence from a Discrete Choice Experiment pp. 403-414 Downloads
Sakil Syeed, Chia Jie Tan, Amandeep Godara, Kyna Gooden, Derek Tang, Samantha Slaff, Yu-Hsuan Shih, Surachat Ngorsuraches and Nathorn Chaiyakunapruk
Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated Price and Cost Savings for Cancer Drugs pp. 415-427 Downloads
Daniel Tobias Michaeli and Thomas Michaeli
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma pp. 429-440 Downloads
Huang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, Tzu-I. Wu, Li-Jun Chen and Szu-Chun Yang
Home Urine Dipstick Screening for Bladder and Kidney Cancer in High-Risk Populations in England: A Microsimulation Study of Long-Term Impact and Cost-Effectiveness pp. 441-452 Downloads
Olena Mandrik, Chloe Thomas, Edifofon Akpan, James W. F. Catto and Jim Chilcott
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study pp. 453-467 Downloads
Kathleen Manipis, Paula Cronin, Deborah Street, Jody Church, Rosalie Viney and Stephen Goodall

Volume 43, issue 3, 2025

Application of Multi-level Network Meta-Regression in the NICE Technology Appraisal of Quizartinib for Induction, Consolidation and Maintenance Treatment of Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukaemia: An External Assessment Group Perspective pp. 243-247 Downloads
Sarah J. Nevitt, David M. Phillippo, Robert Hodgson, Nicky J. Welton and Sofia Dias
Economic Evaluations of Non-Pharmacological Interventions for Treating Disorders of Gut-Brain Interaction: A Scoping Review pp. 249-269 Downloads
Anton Pak, Madeline O’Grady, Gerald Holtmann, Ayesha Shah and Haitham Tuffaha
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA pp. 271-282 Downloads
Xiaomo Xiong and Jeff Jianfei Guo
Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia pp. 283-296 Downloads
Qunfei Chen, Martin Hoyle, Varinder Jeet, Yuanyuan Gu, Kompal Sinha and Bonny Parkinson
A Multistate Model Incorporating Relative Survival Extrapolation and Mixed Time Scales for Health Technology Assessment pp. 297-310 Downloads
Enoch Yi-Tung Chen, Paul W. Dickman and Mark S. Clements
Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States pp. 311-329 Downloads
Hiral Anil Shah, Ginita Jutlla, Oscar Herrera-Restrepo, Jonathan Graham, Katherine A. Hicks, Justin Carrico, Mei Grace, Diana E. Clements, Cindy Burman, Woo-Yun Sohn, Elise Kuylen, Shahina Begum and Zeki Kocaata
Immediate Versus 5-Year Risk-Guided Initiation of Treatment for Primary Prevention of Cardiovascular Disease for Australians Aged 40 Years: A Health Economic Analysis pp. 331-349 Downloads
Jedidiah I. Morton, Danny Liew, Gerald F. Watts, Sophia Zoungas, Stephen J. Nicholls, Christopher M. Reid and Zanfina Ademi
Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer pp. 351-361 Downloads
Trang T. H. Nguyen and Shweta Mital

Volume 43, issue 2, 2025

The Use of Real-World Data for Estimating Relative Treatment Effects in NICE Health Technology Assessment Submissions: A Review pp. 123-131 Downloads
Yoojung Che, Stephen Duffield and Manuel Gomes
A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology pp. 133-151 Downloads
Sietse Mossel, Rafael Emilio Feria Cardet, Lioe-Fee Geus-Oei, Dennis Vriens, Hendrik Koffijberg and Sopany Saing
Costs of Care in Relation to Alzheimer’s Disease Severity in Sweden: A National Registry-Based Cohort Study pp. 153-169 Downloads
Sandar Aye, Oskar Frisell, Henrik Zetterberg, Tobias Borgh Skillbäck, Silke Kern, Maria Eriksdotter, Emil Aho, Xin Xia, Bengt Winblad, Anders Wimo and Linus Jönsson
Measuring Effectiveness Based on Patient Experience (Instead of QALYs) in US Value Assessments pp. 171-176 Downloads
Maksat Jumamyradov and Benjamin M. Craig
Recurrence of Cardiovascular Events After an Acute Myocardial Infarction in Patients with Multivessel Disease and Associated Healthcare Costs: A German Claims Data Analysis pp. 177-189 Downloads
Alexandra Starry, Nils Picker, Jonathan Galduf, Ulf Maywald, Axel Dittmar and Stefan G. Spitzer
Value-Based Healthcare in Practice: IDEATE, a Collaboration to Design and Test an Outcomes-Based Agreement for a Medicine in Wales pp. 191-207 Downloads
Jessica R. Burton, Kate Halsby, Graciela Sáinz Fuente, Jonathan Pearson-Stuttard, Rebecca Sloan, Thomas Porter, Gareth John, Andrew Warburton, Jennifer Selby, Gail Povey, Ruhe Chowdhury, Catherine Bale, Mark Davies, Emma Clifton-Brown and Hamish Laing
Comparison of EQ-5D-Y-3L Utility Scores Using Nine Country-Specific Value Sets in Chinese Adolescents pp. 209-221 Downloads
Ya’nan Wu, Yanjiao Xu, Zhao Shi, Junchao Feng, Zhihao Yang, Zhuxin Mao, Lei Dou and Shunping Li
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications pp. 223-239 Downloads
Julie A. Campbell, Glen J. Henson, Valery Fuh Ngwa, Hasnat Ahmad, Bruce V. Taylor, Ingrid Mei and Andrew J. Palmer
Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications pp. 241-241 Downloads
Julie A. Campbell, Glen J. Henson, Valery Fuh Ngwa, Hasnat Ahmad, Bruce V. Taylor, Ingrid Mei and Andrew J. Palmer

Volume 43, issue 1, 2025

Design and Features of Pricing and Payment Schemes for Health Technologies: A Scoping Review and a Proposal for a Flexible Need-Driven Classification pp. 5-29 Downloads
Vittoria Ardito, Oriana Ciani and Michael Drummond
Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy pp. 31-43 Downloads
Maddalena Centanni, Janine Nijhuis, Mats O. Karlsson and Lena E. Friberg
How Much Better is Faster? Empirical Tests of QALY Assumptions in Health-Outcome Sequences pp. 45-52 Downloads
F. Reed Johnson, John J. Sheehan, Semra Ozdemir, Matthew Wallace and Jui-Chen Yang
Managed Entry Agreements for High-Cost, One-Off Potentially Curative Therapies: A Framework and Calculation Tool to Determine Their Suitability pp. 53-66 Downloads
Marcelien H. E. Callenbach, Rick A. Vreman, Christine Leopold, Aukje K. Mantel-Teeuwisse and Wim G. Goettsch
The Impact of Tocilizumab Coverage on Health Equity for Inpatients with COVID-19 in the USA: A Distributional Cost-Effectiveness Analysis pp. 67-82 Downloads
Stacey Kowal and Katherine L. Rosettie
Economic Burden Associated with Pulmonary Arterial Hypertension in the United States pp. 83-91 Downloads
Anna Watzker, Adnan Alsumali, Christine Ferro, Gabriela Dieguez, Clare Park, Dominik Lautsch and Karim El-Kersh
Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation pp. 93-107 Downloads
Prayash Chaudhary, Lars Thore Fadnes, Steinar Fosse, Fatemeh Chalabianloo and Kjell Arne Johansson
Estimating the Incremental Cost Per QALY Produced by the Spanish NHS: A Fixed-Effect Econometric Approach pp. 109-122 Downloads
Laura Vallejo-Torres
Page updated 2025-06-04